PROGRAM
Programme will be added once finalised.
Check the program of the previous edition HERE
This edition will feature the following themes:
- Next-Generation RNA Therapies: From mRNA to Circular RNA
- Exploring the Future of CARs (ex vivo & in vivo)
- Gene Editing: Shaping the Future Today
- EVs and the Secretome: From Biology to Therapy
- Quality and Technical Challenges in Advanced Therapies
Speakers already confirmed
Massimiliano Gnecchi
PI, Associate Professor
Università di Pavia
Inna Menkova
CEO
Allogenica
Carmen Sanges
Executive Board Member
T2EVOLVE
Philippe Mangeot
Researcher
CIRI - International Center for Infectiology Research
Chantal Lagresle
Researcher
Imagine Institute
Alexandre Hill
CEO
Serendip innovations
Boris Greber
Managing Director
Catalent Pharma Solutions
Emiliano Ricci
Researcher
ENS Lyon
DAY 1
Wednesday, 27 May 2026
8h15
Welcome coffee and registration
8h45
Welcome address
- Plenary
Chairman
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
9h15
Keynote lecture
- Plenary
Chairman
9h15
To be determined
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
9h45
Track 1: Next-Generation RNA Therapies: From mRNA to Circular RNA
- Plenary
Chairman
9h45
Title to be confirmed
Alexandre Hill
CEO
Serendip Innovations - France
10h05
Title to be confirmed
Philippe Mangeot
Researcher
(CIRI) International Center for Infectiology Research - France
10h25
Title to be confirmed
Chantal Lagresle
Researcher
Imagine Institute - France
10h45
Q&A Session
11h00
Coffee break - Exhibition Hall
11h30
Roundtable
- Plenary
Animated by MabDesign
Prénom Nom
Mettre à jour le poste
Entreprise -Pays
12h15
Lunch - Exhibition Hall - B2B Meetings
14h00
Keynote lecture
- Plenary
Chairman
14h00
To be determined
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
14h30
Track 2: Exploring the Future of CARs (ex vivo & in vivo)
- Plenary
Chairman
14h30
Title to be confirmed
Carmen Sanges
Executive Board Member
T2EVOLVE - Germany
14h50
Metabolically Programmed Hyper-Targeting Pluripotent Stem Cell Derived Natural Killer Cells for Adoptive Cell Immunotherapy
Niels-Bjarne Woods
Associate Professor, Section Molecular Medicine and Gene Therapy
Lund University - Sweden
15h10
Title to be confirmed
Inna Menkova
CEO
Allogenica - France
15h30
Q&A Session
15h40
Short break
15h45
Workshops
Workshop 1
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
Workshop 2
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
16h30
Coffe Break - Exhibition Hall - B2B Meetings
17h00
Breakthrough innovation session
- Plenary
Chairman
17h00
Sponsor Slot
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
17h15
Sponsor Slot
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
17h30
Pitch 1
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
17h40
Pitch 2
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
17h50
Pitch 3
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
18h00
Pitch 4
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
18h10
Pitch 5
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
18h20
Pitch 6
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
18h30
End of day 1
DAY 2
Friday, 28 May 2026
8h15
Welcome coffee and registration
8h45
Keynote lecture
- Plenary
Chairman
8h45
Title to be confirmed
Massimiliano Gnecchi
PI, Associate Professor
Università di Pavia - Italy
9h15
Track 3: Gene Editing: Shaping the Future Today (CRISPR, microbiote, iPS, etc)
- Plenary
Chairman
9h15
Title to be confirmed
Boris Greber
Managing Director
Catalent Pharma Solutions - France
9h35
Title to be confirmed
Emiliano Ricci
Researcher
ENS Lyon - France
9h55
Title to be confirmed
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
10h15
Q&A Session
10h30
Coffee break - Exhibition Hall
11h00
Roundtable
- Plenary
Chairman
11h00
To be determined
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
12h00
Lunch - Exhibition Hall - B2B Meetings
14h00
Keynote lecture
- Plenary
Chairman
14h00
Title to be confirmed
Marta Coasta
Mettre à jour le poste
iBET - Portugal
14h30
Track 4: EVs and the Secretome: From Biology to Therapy
- Plenary
Chairman
14h30
Title to be confirmed
Prénom Nom
Mettre à jour le poste
EverZom - France
14h50
Speaker 2
Andre Görgens
Mettre à jour le poste
Entreprise - Pays
15h10
Speaker 3
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
15h30
Q&A Session
15h45
Coffee break - Exhibition Hall
16h15
Track 5: Quality and Technical Challenges in Advanced Therapies
- Plenary
Chairman
16h15
Title to be confirmed
Christine Baldeschi
Researcher
I-Stem - France
16h35
Speaker 2
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
16h55
Speaker 3
Prénom Nom
Mettre à jour le poste
Entreprise - Pays
17h15
Q&A Session
17h30
